Fox Business
Expand
Browse All Video
Watch Live

You're watching...

Vivus Says Europe Likely to Reject Obesity Drug

Details

  • Description

    FBN's Lori Rothman breaks down late-morning market news

  • Duration 0:56
  • Date

Clips

Also in this playlist...

Latest Video

Auto-advance: ON

Auto-advance
View All

Transcript

This transcript is automatically generated

-- -- -- This is very stock keeping -- -- upward trend on this last trading day of the week right now the Dow is up 24 points -- 200611.

I'm back -- going over this fiscal could think for investors love -- 1% drop in the market says according to a worst case near by analysts at Citi research.

-- congress getting -- to leave -- until after the election and no visible progress on the fiscal -- the worst case scenario could become reality.

Did its shares under some pressure here.

On worries -- he's he's got me not get approval in Europe pharmaceutical company says.

The European medicines agency committee signaled it would not clear that we must step -- back to live in this.

Won approval from US and the US Food and Drug Administration marking the second FDA clearance for -- -- -- time in less than a month.

And that is your latest -- business from the Fox Business Network giving you that.

Load More